Insider · CIK 0001967717
Johanne Kaplan
Files at PMN (ProMIS Neurosciences Inc.). First filing Feb 23, 2026, latest Feb 23, 2026.
Johanne Kaplan files SEC Form 4 as officer at PMN (ProMIS Neurosciences Inc.). Since Feb 23, 2026, Johanne Kaplan has reported 1 open-market buy worth $25k and 0 open-market sells worth $0, the latest filed on Feb 23, 2026.
A track record needs three past buys with six months of prices behind them; Johanne Kaplan has 0, so none is measured yet.
The newest scored trade: bought $25k of PMN on Feb 19, 2026, filed Feb 23, 2026, scored 46 (moderate). In the last 12 months: 1 buy worth $25k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PMN: ProMIS Neurosciences Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | ProMIS Neurosciences Inc. | $25k 1,629 shares | +70% | +139% from low-42% from high |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 22, 2026 |
| Feb 19, 2026 | PMN ProMIS Neurosciences Inc. | POpen-market purchase Common Shares | +1,629 | $15.35 | $25k | 3,941 | Feb 23, 2026 |
| Feb 3, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Common Shares | +2,060 | $12.13 | $25k | 2,312 | Feb 5, 2026 |
| Feb 3, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Warrants to purchase Common Sharesderivative | +2,060 | - | - | 2,060 | Feb 5, 2026 |
| Sep 22, 2025 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +165,000 | $0.00 | $0 | 165,000 | Sep 24, 2025 |
| Nov 18, 2024 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Nov 20, 2024 |
Questions about Johanne Kaplan
Answered from the filings on this page, as of the latest one.
Is Johanne Kaplan buying or selling?
In the last 12 months Johanne Kaplan reported 1 open-market buy worth $25k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $25k of PMN on Feb 19, 2026. Grants, option exercises and tax withholding are not counted.
How did Johanne Kaplan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Johanne Kaplan has 0.
Where does Johanne Kaplan file Form 4?
Johanne Kaplan has filed Form 4 at PMN (ProMIS Neurosciences Inc.) as Chief Development Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.